Two-dimensional nanomaterials in cancer theranostics

Jiuhai Wang, Mo Yang

Research output: Chapter in book / Conference proceedingChapter in an edited book (as author)Academic researchpeer-review

4 Citations (Scopus)

Abstract

In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

Original languageEnglish
Title of host publicationTheranostic Bionanomaterials
PublisherElsevier
Pages263-288
Number of pages26
ISBN (Electronic)9780128153413
ISBN (Print)9780128153420
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • 2d nanomaterials
  • Drug release
  • Theranostics
  • Tumor therapy

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this